Conclusion: The combination of gemcitabine and vinorelbine is an effective and tolerable regimen for HER2-negative, taxane-pretreated, metastatic breast cancer patients in Japan.Chemotherapy 2017;62:307-313 (Source: Chemotherapy)
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2rTliVq
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου